For laboratory research use only — not for human or veterinary use. Not evaluated by the U.S. FDA.
GH Secretagogue Peptide
GHRP-2
A synthetic hexapeptide ghrelin-receptor agonist, studied in research models as a growth-hormone secretagogue.
Quantity
$36.99
Bundle & save
Delivery
Order by 3:00 PM ET for same-day dispatch
Cutoff 3:00 PM ET · same-day dispatch
Estimated arrival in 2–3 business days
Overnight shipping available
Free shipment protection included
GHRP-2
1 × 10mg · $36.99
99% purity, QC passed
HPLC + mass-spec verified
Shipment protection
Free on every order
Free shipping over $150
Same-day dispatch before 3PM ET
Certificate of Analysis
Third-party tested · Independent analytical lab
10mg
99.22%latest
| Tested | Measured | Purity |
|---|---|---|
| Apr 2026 | 11.16mg | 99.22% |
| Mar 2026 | 11.30mg | 99.66% |
Frequently researched together
Commonly studied alongside GHRP-2.
Compound information
Technical specifications
Molecular profile
| Type | Synthetic growth-hormone secretagogue hexapeptide |
| CAS number | 158861-67-7 |
| Molecular weight | 818.0 g/mol |
| Amino acids | 6 |
| Sequence | D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 |
| Formula | C45H55N9O6 |
Storage & stability
- ❄️
Lyophilized (powder)
-20°C · stable 2+ years
- ❄️
Reconstituted
2–8°C · use within 30 days
Sources & references
Peer-reviewed literature, for research context
- Drugs in R&D
Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN
2004·DOI: 10.2165/00126839-200405040-00011·PMID: 15230633View source - The Journal of clinical endocrinology and metabolism
Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men
2005·DOI: 10.1210/jc.2004-1719·PMID: 15699539Laferrère B, Abraham C, Russell CD, Bowers CY
View source - Arzneimittel-Forschung
Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide
2004·DOI: 10.1055/s-0031-1297041·PMID: 15646370Doi N, Hirotani C, Ukai K, Shimada O, Okuno T, Kurasaki S
View source - Journal of the Endocrine Society
Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder
2022·DOI: 10.1210/jendso/bvac088·PMID: 35795807Suzuki S, Ruike Y, Ishiwata K, Naito K, Igarashi K, Ishida A
View source
Important research notice
Not for human consumption. This product is sold exclusively for laboratory and in vitro research. It is not intended to diagnose, treat, cure, or prevent any disease.
Any research findings referenced on this page are drawn from published, peer-reviewed literature and are provided for educational context only. They are not product claims and should not be read as medical advice.
By purchasing, you confirm you are a qualified researcher and will handle this material in accordance with all applicable laws and institutional guidelines.